CUE CUE BIOPHARMA INC More: the full row for CUE BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 52,928 shares; 2026Q3: 52,928 shares 52,928 $1.37M 7.93% 0 Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 5,700 shares; 2025Q4: 4,450 shares; 2026Q1: 4,450 shares; 2026Q2: 4,450 shares; 2026Q3: 4,450 shares 4,450 $1.3M 7.51% 0 Timeline RPRX ROYALTY PHARMA PLC More: the full row for ROYALTY PHARMA PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 21,400 shares; 2025Q4: 21,400 shares; 2026Q1: 21,400 shares; 2026Q2: 21,400 shares; 2026Q3: 21,400 shares 21,400 $1.25M 7.24% 0 Timeline FENC FENNEC PHARMACEUTICALS INC More: the full row for FENNEC PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 195,700 shares; 2025Q1: 195,700 shares; 2025Q2: 195,700 shares; 2025Q3: 123,000 shares; 2025Q4: 112,434 shares; 2026Q1: 112,434 shares; 2026Q2: 112,434 shares; 2026Q3: 112,434 shares 112,434 $1.2M 6.94% 0 Timeline CMPS COMPASS PATHWAYS PLC More: the full row for COMPASS PATHWAYS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 58,000 shares; 2025Q4: 58,000 shares; 2026Q1: 80,000 shares; 2026Q2: 80,000 shares; 2026Q3: 80,000 shares 80,000 $995K 5.77% 0 Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 67,500 shares; 2025Q4: 67,500 shares; 2026Q1: 67,500 shares; 2026Q2: 67,500 shares; 2026Q3: 67,500 shares 67,500 $790K 4.58% 0 Timeline GERN GERON CORP More: the full row for GERON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,000 shares; 2025Q1: 500,000 shares; 2025Q2: 500,000 shares; 2025Q3: 500,000 shares; 2025Q4: 578,000 shares; 2026Q1: 578,000 shares; 2026Q2: 578,000 shares; 2026Q3: 578,000 shares 578,000 $711K 4.12% 0 Timeline MIST MILESTONE PHARMACEUTICALS IN More: the full row for MILESTONE PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,025,806 shares; 2025Q1: 548,806 shares; 2025Q2: 548,806 shares; 2025Q3: 658,553 shares; 2025Q4: 755,000 shares; 2026Q1: 820,000 shares; 2026Q2: 820,000 shares; 2026Q3: 820,000 shares 820,000 $710K 4.11% 0 Timeline BHVN BIOHAVEN LTD More: the full row for BIOHAVEN LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 22,700 shares; 2025Q1: 22,700 shares; 2025Q2: 22,700 shares; 2025Q3: 22,700 shares; 2025Q4: 51,700 shares; 2026Q1: 51,700 shares; 2026Q2: 51,700 shares; 2026Q3: 51,700 shares 51,700 $690K 4% 0 Timeline SNDX SYNDAX PHARMACEUTICALS INC More: the full row for SYNDAX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 55,000 shares; 2025Q1: 55,000 shares; 2025Q2: 55,000 shares; 2025Q3: 55,000 shares; 2025Q4: 36,000 shares; 2026Q1: 36,000 shares; 2026Q2: 36,000 shares; 2026Q3: 36,000 shares 36,000 $677K 3.92% 0 Timeline BNTC BENITEC BIOPHARMA INC More: the full row for BENITEC BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 62,000 shares; 2025Q1: 62,000 shares; 2025Q2: 62,000 shares; 2025Q3: 62,000 shares; 2025Q4: 62,000 shares; 2026Q1: 62,000 shares; 2026Q2: 62,000 shares; 2026Q3: 62,000 shares 62,000 $620K 3.59% 0 Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,600 shares; 2025Q1: 10,600 shares; 2025Q2: 10,600 shares; 2025Q3: 10,600 shares; 2025Q4: 8,100 shares; 2026Q1: 8,100 shares; 2026Q2: 8,100 shares; 2026Q3: 8,100 shares 8,100 $530K 3.07% 0 Timeline SRPT SAREPTA THERAPEUTICS INC More: the full row for SAREPTA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 28,500 shares; 2026Q1: 28,500 shares; 2026Q2: 28,500 shares; 2026Q3: 28,500 shares 28,500 $519K 3.01% 0 Timeline KURA KURA ONCOLOGY INC More: the full row for KURA ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 46,000 shares; 2025Q4: 46,000 shares; 2026Q1: 46,000 shares; 2026Q2: 46,000 shares; 2026Q3: 46,000 shares 46,000 $493K 2.85% 0 Timeline VTRS VIATRIS INC More: the full row for VIATRIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 27,700 shares; 2026Q1: 27,700 shares; 2026Q2: 27,700 shares; 2026Q3: 27,700 shares 27,700 $491K 2.84% 0 Timeline ARDX ARDELYX INC More: the full row for ARDELYX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 335,400 shares; 2025Q1: 335,400 shares; 2025Q2: 335,400 shares; 2025Q3: 162,750 shares; 2025Q4: 128,650 shares; 2026Q1: 128,650 shares; 2026Q2: 128,650 shares; 2026Q3: 128,650 shares 128,650 $440K 2.55% 0 Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 9,100 shares; 2026Q1: 9,100 shares; 2026Q2: 9,100 shares; 2026Q3: 9,100 shares 9,100 $369K 2.14% 0 Timeline QURE UNIQURE NV More: the full row for UNIQURE NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 14,700 shares; 2026Q1: 14,700 shares; 2026Q2: 14,700 shares; 2026Q3: 14,700 shares 14,700 $355K 2.06% 0 Timeline AZTA AZENTA INC More: the full row for AZENTA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 9,700 shares; 2026Q1: 9,700 shares; 2026Q2: 9,700 shares; 2026Q3: 9,700 shares 9,700 $338K 1.96% 0 Timeline PCRX PACIRA BIOSCIENCES INC More: the full row for PACIRA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 13,500 shares; 2026Q1: 13,500 shares; 2026Q2: 13,500 shares; 2026Q3: 13,500 shares 13,500 $338K 1.96% 0 Timeline HUMA HUMACYTE INC More: the full row for HUMACYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 83,500 shares; 2025Q2: 83,500 shares; 2025Q3: 83,500 shares; 2025Q4: 500,000 shares; 2026Q1: 650,000 shares; 2026Q2: 650,000 shares; 2026Q3: 650,000 shares 650,000 $337K 1.95% 0 Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 40,300 shares; 2025Q1: 26,000 shares; 2025Q2: 26,000 shares; 2025Q3: 13,300 shares; 2025Q4: 5,000 shares; 2026Q1: 5,000 shares; 2026Q2: 5,000 shares; 2026Q3: 5,000 shares 5,000 $329K 1.91% 0 Timeline JANX JANUX THERAPEUTICS INC More: the full row for JANUX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 19,000 shares; 2026Q1: 19,000 shares; 2026Q2: 19,000 shares; 2026Q3: 19,000 shares 19,000 $328K 1.9% 0 Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 18,000 shares; 2026Q1: 18,000 shares; 2026Q2: 18,000 shares; 2026Q3: 18,000 shares 18,000 $290K 1.68% 0 Timeline JSPR JASPER THERAPEUTICS INC More: the full row for JASPER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 32,000 shares; 2025Q1: 146,500 shares; 2025Q2: 146,500 shares; 2025Q3: 398,558 shares; 2025Q4: 465,000 shares; 2026Q1: 465,000 shares; 2026Q2: 465,000 shares; 2026Q3: 465,000 shares 465,000 $270K 1.56% 0 Timeline MLYS MINERALYS THERAPEUTICS INC More: the full row for MINERALYS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 79,000 shares; 2025Q1: 79,000 shares; 2025Q2: 79,000 shares; 2025Q3: 39,000 shares; 2025Q4: 10,500 shares; 2026Q1: 10,500 shares; 2026Q2: 10,500 shares; 2026Q3: 10,500 shares 10,500 $264K 1.53% 0 Timeline GHRS GH RESEARCH PLC More: the full row for GH RESEARCH PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,200 shares; 2026Q1: 10,200 shares; 2026Q2: 10,200 shares; 2026Q3: 10,200 shares 10,200 $239K 1.39% 0 Timeline RCKT ROCKET PHARMACEUTICALS INC More: the full row for ROCKET PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 86,000 shares; 2025Q4: 86,000 shares; 2026Q1: 86,000 shares; 2026Q2: 86,000 shares; 2026Q3: 86,000 shares 86,000 $226K 1.31% 0 Timeline RGNX REGENXBIO INC More: the full row for REGENXBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 57,750 shares; 2025Q1: 57,750 shares; 2025Q2: 57,750 shares; 2025Q3: 57,750 shares; 2025Q4: 26,600 shares; 2026Q1: 26,600 shares; 2026Q2: 26,600 shares; 2026Q3: 26,600 shares 26,600 $200K 1.16% 0 Timeline INVA INNOVIVA INC More: the full row for INNOVIVA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 8,200 shares; 2026Q1: 8,200 shares; 2026Q2: 8,200 shares; 2026Q3: 8,200 shares 8,200 $174K 1.01% 0 Timeline ARQT ARCUTIS BIOTHERAPEUTICS INC More: the full row for ARCUTIS BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 46,300 shares; 2025Q1: 46,300 shares; 2025Q2: 46,300 shares; 2025Q3: 35,300 shares; 2025Q4: 5,250 shares; 2026Q1: 5,250 shares; 2026Q2: 5,250 shares; 2026Q3: 5,250 shares 5,250 $139K 0.8% 0 Timeline IPHA INNATE PHARMA S A More: the full row for INNATE PHARMA S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 81,151 shares; 2026Q1: 81,151 shares; 2026Q2: 81,151 shares; 2026Q3: 81,151 shares 81,151 $132K 0.77% 0 Timeline MCRB SERES THERAPEUTICS INC More: the full row for SERES THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 17,038 shares; 2025Q3: 27,138 shares; 2025Q4: 31,570 shares; 2026Q1: 31,570 shares; 2026Q2: 31,570 shares; 2026Q3: 31,570 shares 31,570 $106K 0.61% 0 Timeline SPRB SPRUCE BIOSCIENCES INC More: the full row for SPRUCE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,000 shares; 2025Q4: 1,000 shares; 2026Q1: 1,000 shares; 2026Q2: 1,000 shares; 2026Q3: 1,000 shares 1,000 $48.6K 0.28% 0 Timeline